PET
18FDG viability imaging is frequently used to guide clinical decision-making on the role of revascularization in high-risk patients with heart failure and reduced left ventricular function, coronary artery disease (CAD) and significant comorbidities. Several observational nonrandomized studies have shown that patients with viability will likely benefit from revascularization,
1‐
5 with improvement in left ventricular function
1,
5 and survival.
1 The amount of hibernating myocardium can predict the degree of recovery of function and outcome benefit.
4 However, 4 randomized studies evaluating the value of viability imaging in patients undergoing revascularization have failed to demonstrate outcome differences.
6‐
10 …
